Eli Khankin
Executive Director Apellis Pharmaceuticals
Seminars
Wednesday 19th August 2026
Navigating the Clinical & Regulatory Pathway to Approval in Rare Kidney Disease
2:00 pm
- Demonstrating efficacy across multiple endpoints to support regulatory decisionmaking in rare kidney disease
- Designing clinical programs that balance feasibility with the need for robust and clinically meaningful data
- Overcoming challenges associated with small, heterogeneous patient populations in late-stage development
